Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
To evaluate in combination with corticosteroid and local standard medical care the efficacy
and safety of long-acting octreotide compared to placebo for the treatment of symptoms of
inoperable bowel obstruction in patients with peritoneal carcinomatosis